Results 31 to 40 of about 239,825 (303)

The association of aspirin use with overall survival of patients with inoperable non-small cell lung cancer: a retrospective study

BMC Cancer, 2021
Background Studies have indicated that individuals taking aspirin have a reduced risk of cancers and have also established chemo-preventive benefit of aspirin in colorectal cancer. However, research on the association between aspirin use and the survival
Min-Chun Chuang, Yao-Hsu Yang, Meng-Jer Hsieh, Yu-Ching Lin, Tsung-Ming Yang, Pau-Chung Chen, Ming-Szu Hung   +6 more
doaj   +1 more source

Aspirin “Allergy”-Induced Thrombocytopenia: A Case Report

Journal of Asthma and Allergy, 2021
Wei Fu, Shanshan Xu, Xiang Dong, Qing Xie, Yadong Gao Department of Allergology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People’s Republic of ChinaCorrespondence: Yadong Gao; Wei FuDepartment of Allergology, Zhongnan Hospital of Wuhan ...
Fu W, Xu S, Dong X, Xie Q, Gao Y
doaj  

Aspirin resistance in patients with acute coronary syndrome. Part 2

Кардиоваскулярная терапия и профилактика, 2011
Aim. In patients with acute coronary syndrome (ACS), to investigate the prevalence of aspirin resistance, its clinical features, prognostic effects, and potential correction. Material and methods.
N. S. Frolova, R. M. Shakhnovich, E. M. Kaznacheeva, O. V. Sirotkina, A. B. Dobrovolskyi   +4 more
doaj   +1 more source

Drug insight: aspirin resistance- fact or fashion

, 2007
The term aspirin resistance has been used increasingly in clinical studies. The aim of this Review is to analyze the origin of this term, to discuss the biochemical, functional and clinical correlates of the phenomenon and to offer a conceptual framework
Carlo Patrono, Patrono, Carlo, Bianca Rocca, Rocca, Bianca   +3 more
core   +1 more source

'Aspirin resistance' or treatment non-compliance: Which is to blame for cardiovascular complications?

Journal of Translational Medicine, 2008
Aspirin is one of the 'cornerstone' drugs in our current management of cardiovascular disorders. However, despite the prescription of aspirin recurrent vascular events still occur in 10–20% of patients.
Shantsila Eduard, Lip Gregory YH
doaj   +1 more source

Frequency of Aspirin Resistance in Ischemic Stroke Patients and Healthy Controls from Colombia

Stroke Research and Treatment, 2021
Objective. To evaluate the aspirin resistance prevalence in patients with previous ischemic cerebrovascular disease undergoing aspirin therapy for secondary prevention. Materials and Methods.
Alejandro Roman-Gonzalez, Carlos Andrés Naranjo, Walter D. Cardona-Maya, Dionis Vallejo, Francisco Garcia, Cesar Franco, Leonor Alvarez, Luis Ignacio Tobón, Marta Ibeth López, Carolina Rua, Gabriel Bedoya, Ángela Cadavid, José Domingo Torres   +12 more
doaj   +1 more source

Contextualizing National Policies Regulating Access to Low‐Dose Aspirin in America and Europe Using the Full Report of a Transatlantic Patient Survey of Aspirin in Preventive Cardiology

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Aspirin is widely administered to prevent cardiovascular disease (CVD). However, appropriate use of aspirin depends on patient understanding of its risks, benefits, and indications, especially where aspirin is available over the counter (OTC).
Alan P. Jacobsen, Zi Lun Lim, Blair Chang, Kaleb D. Lambeth, Thomas M. Das, Colin Gorry, Michael McCague, Faisal Sharif, Darren Mylotte, William Wijns, Patrick W. J .C. Serruys, Roger S. Blumenthal, Seth S. Martin, John W. McEvoy   +13 more
doaj   +1 more source

Survival of HGG patients in relation to statin, aspirin or non-aspirin-NSAID use.

, 2018
Survival of HGG patients in relation to statin, aspirin or non-aspirin-NSAID use.
Michael F. Leitzmann (352586), Martin Proescholdt (322623), Julia Schaertl (6037814), Michael Gerken (2078125), Peter Hau (431793), Markus J. Riemenschneider (636437), Corinna Seliger (478759), Monika Klinkhammer-Schalke (3425441), Christian Luber (6037817)   +8 more
core   +1 more source

286 Genetic, laboratory and clinical factors associated with low-dose aspirin failure in the prevention of preeclampsia

Journal of Clinical and Translational Science, 2023
OBJECTIVES/GOALS: Low-dose aspirin is an established treatment to prevent preeclampsia, a leading cause of maternal and perinatal complications. Nevertheless, aspirin failure is not uncommon.
Amihai Rottenstreich, Roger Vaughan, Barry S Coller   +2 more
doaj   +1 more source

Effects of Aspirin and Prednisone on Platelet Function and Thromboxane Synthesis in Healthy Dogs

Frontiers in Veterinary Science, 2019
Glucocorticoid administration is a risk factor for thromboembolism in hypercoagulable dogs, and it is unknown if aspirin counteracts glucocorticoid-induced hypercoagulability. The objective was to determine the effects of sustained aspirin and prednisone
John M. Thomason, Allison P. Mooney, Joshua M. Price, Jacqueline C. Whittemore   +3 more
doaj   +1 more source